Margins, Megaprojects and the Missing Payoff Across India’s Chemical Sector
This edition covers:
- Chemplast's replacement PVC spread supports positive EBITDA; pre-tax recovery still needs a wider margin
- UFlex's 17% EBITDA margin contains a supply-crisis premium that management expects to normalize
- Insecticides India's premium mix lifted gross margin while Q1 volume and EBITDA fell
- Grasim's specialty mix lifted chemical EBITDA, but Q2 must absorb higher-cost inputs
- Clean Science kept a 37.7% EBITDA margin while consolidated revenue declined
- Sanathan's Punjab plant is near 90% utilisation; Q1 margin and debt service now define the ramp
- Chemfab completed its cost and pipe-capacity projects during a two-market slowdown
- Sudeep doubled its pCAM ambition to 200,000 tonnes; PL Research says the market may not reward capacity alone
- TCPL's packaging plants are earning now; its battery-separator project must still qualify
- Shaily's injector revenue rose 85% while machine utilisation stayed near 50%
- Tatva Chintan's credit cushion remains strong, but Crisil cannot complete the next review
- Camlin's ethyl-vanillin approvals are ahead of the utilisation needed for positive EBITDA
- Gulshan Polyols gets 59% of turnover from ethanol while grain and water set the operating limit
- Garware's geosynthetics order book strengthened while aquaculture deferrals cut group EBITDA
- Indo Amines says group impact may be limited while the Mahad shutdown remains unquantified
The complete bulletin is available to subscribers.

